Purchases and Sales Made in Q3 2022 in Pasithea Therapeutics Corp. (KTTA)
This table provides information about the institutional ownership of Pasithea Therapeutics Corp. (KTTA) during Q3 2022. The information is specifically focused on institutions that hold shares of Pasithea Therapeutics Corp..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
81.7K+ 104.56% |
$6.54K - $2.16M
|
160K
$601K
|
|
|
Nov 14, 2022
Q3 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
78.9K+ 399.84% |
$6.31K - $2.08M
|
98.6K
$371K
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
3.41K+ 151.06% |
$272 - $89.9K
|
5.66K
$21.3K
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
16+ 16.84% |
$1.28 - $422
|
111
$417
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
SELL
|
- |
-7.35K- 57.42% |
$588 - $194K
|
5.45K
$20.5K
|